BIO-key International Files S-1 Registration

Ticker: BKYI · Form: S-1 · Filed: Apr 25, 2025 · CIK: 1019034

Sentiment: neutral

Topics: sec-filing, s-1, registration

TL;DR

BIO-key International filed an S-1, likely prepping for a new stock offering.

AI Summary

BIO-key International, Inc. filed an S-1 registration statement on April 25, 2025, to register securities under the Securities Act of 1933. The company, formerly known as SAC Technologies Inc., is incorporated in Delaware and headquartered in Holmdel, NJ. Michael DePasquale serves as the Chief Executive Officer.

Why It Matters

This S-1 filing indicates BIO-key International is preparing to offer new securities to the public, which could impact its capital structure and stock availability.

Risk Assessment

Risk Level: medium — S-1 filings are standard for public offerings, but the specific details of the offering and the company's financial health will determine the actual risk.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this S-1 filing?

The S-1 filing is a registration statement required by the Securities Act of 1933 for companies planning to offer securities to the public.

When was this S-1 filing submitted?

The S-1 filing was submitted on April 25, 2025.

What is BIO-key International, Inc.'s principal executive office address?

The principal executive offices are located at 101 CRAWFORDS CORNER ROAD, SUITE 4116, HOLMDEL, NJ 07733.

Who is the Chief Executive Officer of BIO-key International, Inc.?

Michael DePasquale is the Chief Executive Officer.

What was BIO-key International, Inc. formerly known as?

The company was formerly known as SAC TECHNOLOGIES INC.

Filing Details

This Form S-1 (Form S-1) was filed with the SEC on April 25, 2025 by Michael DePasquale regarding BIO KEY INTERNATIONAL INC (BKYI).

View full filing on EDGAR

View Full Filing

View this S-1 filing on SEC EDGAR

View on Read The Filing